USPTO serial 97925413
HONNLAB
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Dec 17, 2024
- Examiner
- SOLANO, CARLITA JAYE
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with HONNLAB?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Alcohol for medicinal purposes; Algaecide chemicals for swimming pools; Algaecides; Amalgam for dental purposes; Antibiotic ointments; Antibiotic tablets; Antifungal preparations; Bath preparations for medical purposes; Bath salts and bath preparations for medical purposes; Bone paste for medical purposes; Bone repair paste for use in orthopedic surgery; Breast pads; Capsules sold empty for pharmaceuticals; Cartridges sold pre-filled with gases and gas mixtures for medical use; Ceramic materials for dental use for fillings; Chemical preparations for treating mildew; Chemical preparations for treating phylloxera; Chemical preparations to treat mildew; Chemical preparations to treat wheat smut; Cleaning preparations, namely, odor eliminators not for personal use; Clinical medical reagents for processing human whole blood and its components for use in blood transfusions stored in bags, bottles, syringes and other such containers used to store such substances in the medical field; Compounds for sanitising eggs; Contrast media for use with imaging medical equipment; Cord blood for medical purposes; Dental amalgams of gold; Dental compounds used in endodontic procedures; Dental nitrous oxide; Dental porcelain materials; Dental resin cement; Dental sealants; Dental tablets for disclosing plaque and tartar on the teeth; Diagnostic preparations for veterinary purposes; Dietary food supplements; Dietary pet supplements in the form of pet treats; Dietary supplement for eliminating toxins from the intestinal tract; Dietary supplemental drinks in the nature of vitamin and mineral beverages; Dietary supplements for controlling cholesterol; Dietary supplements for pets in the nature of a powdered drink mix; Disinfectants for contact lenses; Disposable adult diapers; Diuretic preparations; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of powders that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Drug delivery agents in the form of tablets that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Egg sanitizing preparations; Enzyme food supplements; Eyepatches for medical use; Fecal enzyme inhibiting compositions used as an ingredient in medicated creams, ointments and lotions; Feeding stimulants for animals; Glucose for use as an additive to foods for medical purposes; Gold amalgam for dental purposes; Imaging agents for magnetic resonance imaging (MRI); Infant cloth diapers; Infant diaper covers; Lecithin for use as a dietary supplement; Media for use in the augmentation of bone and tissue for medical purposes; Medicated cosmetics; Medicated hair serums; Medicated make-up; Medicated throat sprays; Medicinal preparations for stimulating hair growth; Mentholated ointment for medical use; Modeling wax for dental purposes; Molecular complex for the delivery of non-radical oxygen for medicinal, surgical, therapeutic or veterinary purposes; Nail sanitizing preparations; Nitrous oxide for medical use; Nutritional supplement for eliminating toxins from the intestinal tract; Odor neutralizing preparations for general use on various surfaces; Pesticides for agricultural use; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, dantrolene sodium for injection; Pharmaceutical products for the prevention and treatment of cancer; Placebo mixes for medical use; Placebo pills for medical use; Pre-filled dental trays for applying dental compositions to teeth; Prenatal vitamins; Preparations in the form of granules and liquids for controlling and removing moss; Preparations in the form of powders for controlling and removing moss; Probiotic supplements; Saline solution for medical purposes; Skin lubricants for athletes to prevent skin chafing; Soy protein dietary supplements; Specialized tablets, capsules and powders for the delivery of pharmaceuticals sold without the pharmaceutical ingredient; Sports cream for relief of pain; Stem cells for medical purposes; Stem cells for veterinary purposes; Sugar pills for medical placebo use; Surgical implants comprised of living tissues; Synthetic materials for dental use for fillings; Therapeutic medicated bath preparations | ACTIVE | Jan 1, 2023 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 17, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Dec 17, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 10, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Sep 10, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 21, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Aug 2, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 31, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 31, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 31, 2024 | ALIE | ASSIGNED TO LIE | — |
| Feb 12, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 8, 2024 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2024 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 8, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 1, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 7, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Jun 6, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 11, 2023 | NWAP | NEW APPLICATION ENTERED | — |